28
Substantial CD4+ T-cell Recovery and Reconstitution of Tissue Architecture in Gut-associated Lymphoid Tissue in Advanced HIV-1 Infection following Initiation of HAART
E Connick1, Derek Shenefelt*1,2, Derek Shenefelt*1,2, J Folkvord1, M Thrun3, S MaWhinney1, J Gathe4, S Lundy5, and S Becker6
1Univ of Colorado Hlth Sci Ctr, Denver, US; 2Weber State Univ, Ogden, UT, US; 3Denver Dept of Publ Hlth, CO, US; 4Therapeutic Concepts, Houston, TX, US; 5Pharma Product Devt, Inc, Menlo Park, CA, US; and 6AnorMED Inc, Langley, Canada
Background: Gut-associated lymphoid tissue (GALT) harbors
the majority of CD4+ T cells and is rapidly depleted in early HIV
infection. Previous studies suggest that reconstitution of CD4+ T
cells in HAART-treated individuals is less complete in GALT than in peripheral
blood. Most studies have evaluated GALT by flow cytometry,
which provides relative estimates of CD4+ T cells. We hypothesized
that reconstitution of CD4+ T cells in GALT may have been
underestimated by this method and that absolute numbers of CD4+ T cells
reconstituted in GALT exceed those in peripheral blood.
Methods: We enrolled 8 untreated AIDS patients in a
clinical trial who underwent colonic biopsies and provided peripheral blood
samples at baseline, 24 and 48 weeks after starting nevirapine
(NVP)/trizivir (TZV); 4-μm sections of GALT
biopsies were stained with CD3 and CD4 antibodies, and analyzed by immunofluorescent microscopy. Numbers of lamina propria CD4+ T cells/mm3 were calculated
and tissue histology observed. A mixed model was used to account for within
subject correlations.
Results: All but 1 subject achieved a viral load
<400 copies/mL by week 48. Mean peripheral blood
CD4+ T cells/mm3 increased from 65 at baseline to 192 at
week 24 (p <0.15) and 216 at week
48 (p = 0.08 vs
baseline). Mean GALT CD4+ T cells/mm3 were 279 at
baseline, which was higher than that in peripheral blood (p = 0.08). Mean GALT CD4+ T cells increased through week
24 to 890 cells/mm3 (p <0.0001),
a larger increase than was observed in peripheral blood (p = 0.0006). Mean GALT CD4+ T cells decreased to 759 cells/mm3
at week 48, but remained significantly different than baseline (p <0.0001) and still reflected a
larger increase than in peripheral blood (p
= 0.0096). Peripheral blood and GALT reconstitution were calculated as a
percentage of normal values assuming a norm of 1000 cells/mm3 in peripheral
blood and using values for GALT CD4+ T cells obtained in 2 control
colonic biopsies. At baseline, mean CD4+ T cells were 7% in peripheral
blood and 16% in GALT of normal values (p
= 0.21). At week 24, peripheral blood and GALT values were 19% and 52% (p = 0.011 GALT vs
peripheral blood increase), and at week 48, 22% and 44% (p = 0.12 GALT vs peripheral blood
increase over baseline) of normal values. Lymphoid aggregates were observed in
colonic tissue of 1 subject at baseline, 6 subjects at week 24 (p = 0.04), and 5 subjects at week 48 (p = 0.12 vs
baseline).
Conclusions: NVP/TZV in advanced HIV-1 infection results
in substantial recovery of CD4+ T cells and reconstitution of tissue
architecture in GALT. Increases in CD4+ T cells are significantly larger
in GALT than peripheral blood, particularly during the first 24 weeks of
therapy.
|